Risk of Relapse Up for Teens, Young Adults With Leukemia
Increased risk of on-therapy relapse, relapse after completing therapy versus children with ALL
FDA Approves New Treatment for Squamous Cell Carcinoma
Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
September 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2018. This roundup includes...
Risk of Venous Thromboembolism Recurrence High
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years
Handheld Device Inspired by Star Trek May Allow Rapid Diagnosis
Device uses enzyme-based assays to measure metabolites associated with multiple diseases
Physicians Often Don’t Address Their Burnout
Same traits that help doctors excel at their jobs make them more likely to experience burnout
Practices Should Set Rules for Staff Social Media Use
Staff social media accounts should be strictly personal, with no info about patients or employees
Single Agent Treats Two Cancers With Same Genetic Cause
Pembrolizumab treated colon cancer, intrahepatic cholangiocarcinoma in patient with Lynch syndrome
Newer Hormonal Contraception May Cut Ovarian Cancer Risk
Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use
Business Degree Increasingly Useful for Doctors
With increased focus on value, business analysis skills sought after
